Company · CIK 1855175

# Contineum Therapeutics, Inc.

| CIK | [1855175](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001855175) (SEC EDGAR) |
| --- | --- |
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | CA |
| Listed | CTNM (Nasdaq) |
| First annual or quarterly report | 2024-05-16 |

## Offerings

 2 registrations

| Registration | Label and status | First filed | Last event | Filings |
| --- | --- | --- | --- | --- |
| 333-287275 | Shelf Effective | 2025-05-14 | 2026-03-05 | 5 |
| 333-278003 | IPO Final prospectus | 2024-03-15 | 2024-04-08 | 4 |

## Filings

 10

| Filed | Filing | Registration | Accession |
| --- | --- | --- | --- |
| 2026-03-05 | [424B5](https://www.sec.gov/Archives/edgar/data/1855175/000162828026015205/0001628280-26-015205-index.htm) Shelf takedown | 333-287275 | 0001628280-26-015205 |
| 2025-12-12 | [424B5](https://www.sec.gov/Archives/edgar/data/1855175/000143774925037749/0001437749-25-037749-index.htm) Shelf takedown | 333-287275 | 0001437749-25-037749 |
| 2025-12-11 | [424B5](https://www.sec.gov/Archives/edgar/data/1855175/000143774925037553/0001437749-25-037553-index.htm) Shelf takedown | 333-287275 | 0001437749-25-037553 |
| 2025-05-23 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1855175/999999999525001732/9999999995-25-001732-index.htm) Declared effective | 333-287275 | 9999999995-25-001732 |
| 2025-05-14 | [S-3](https://www.sec.gov/Archives/edgar/data/1855175/000143774925016871/0001437749-25-016871-index.htm) Shelf registered | 333-287275 | 0001437749-25-016871 |
| 2024-04-08 | [424B4](https://www.sec.gov/Archives/edgar/data/1855175/000119312524088740/0001193125-24-088740-index.htm) Final prospectus | 333-278003 | 0001193125-24-088740 |
| 2024-04-04 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1855175/999999999524000863/9999999995-24-000863-index.htm) Declared effective | 333-278003 | 9999999995-24-000863 |
| 2024-04-01 | [S-1/A](https://www.sec.gov/Archives/edgar/data/1855175/000119312524082755/0001193125-24-082755-index.htm) Amendment | 333-278003 | 0001193125-24-082755 |
| 2024-03-15 | [S-1](https://www.sec.gov/Archives/edgar/data/1855175/000119312524069256/0001193125-24-069256-index.htm) Registration filed | 333-278003 | 0001193125-24-069256 |
| 2023-12-13 | [DRS](https://www.sec.gov/Archives/edgar/data/1855175/000095012323011163/0000950123-23-011163-index.htm) Draft made public | 377-06994 | 0000950123-23-011163 |

[All filings of this company](https://equitycapital.markets/filings?cik=1855175) · [CSV](https://equitycapital.markets/filings.csv?cik=1855175)

---
Source page: https://equitycapital.markets/company/1855175 · Data: U.S. SEC EDGAR · CC BY 4.0